Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CloudMD Software & Services Inc V.DOC

Alternate Symbol(s):  DOCRF

CloudMD Software & Services Inc. is a healthcare service provider. The Company operates through two divisions: Health and Wellness Services (HWS) and Health and Productivity Solutions (HPS). HWS operates through two models: subscription-based pricing using a price per member per month with an average contractual term of three years; and a per-case billing model at an agreed-upon rate for... see more

TSXV:DOC - Post Discussion

CloudMD Software & Services Inc > Canaccord analyst
View:
Post by Dartmam32 on Nov 17, 2022 5:30pm

Canaccord analyst

I dont know how the Canaccord analyst Taylor is still employed. He cant even put a decimal in the right place. He was probably trying to type $2.50 and he put .25. Either that or he is probably upset with DOC because they did not do a financing at .25 with Canaccord. These analysts just want to make fees for their firm they dont really care about a company and dilution. If he cant do a proper evaluation he should move on to another company.
Comment by slowcook on Nov 18, 2022 8:31am
CloudMD Software & Services (OTCMKTS:DOCRF) Price Target Lowered to C$0.25 at Canaccord Genuity Group Posted by MarketBeat News on Nov 18th, 2022       CloudMD Software & Services (OTCMKTS:DOCRF – Get Rating) had its price target dropped by Canaccord Genuity Group from C$0.40 to C$0.25 in a research report issued on Wednesday ...more  
Comment by butchtennis on Nov 18, 2022 10:43am
Dartmam...most analysts were recommending DOC when it was trading at $2.70...they are totally incompetent.... As well, Canaccord is probably buying cheap shares at these low prices.... when they have finished loading up...they will place a strong buy on the stock... market manipulation at it's best!!
Comment by vitalina2233 on Nov 18, 2022 12:29pm
That's why pay no nevermind to those crooks target price. Papi
Comment by Defiance2050 on Nov 19, 2022 10:44am
Just look at technology and growth companies even megacaps that have been decimated with over 50% drops. You can argue November 2020 or even fall of 2021 for technologies as a whole dropping.  You have to consider adjusting out the Mindbeacon acquistion and recent loss of revenue; even with the loss of COVID contracts it is possible that DOC would be EBITDA positive presently.  ...more  
Comment by butchtennis on Nov 19, 2022 3:53pm
Defiance...I agree with what you wrote. More than anything, growth stocks got hammered because of the macroeconomics... 1. Supply chain issues stemming from the lock-downs in China due to the zero policy towards COVID 2. The war in Ukraine...the restrictions on Russian oil on world markets...causing inflationary pressures 3. Central banks hiking interest rates to deal with the rising rate of ...more